Citadel Advisors’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$116K Buy
44,000
+31,900
+264% +$75.1K ﹤0.01% 11891
2025
Q4
$23.1K Buy
+12,100
New +$28.7K ﹤0.01% 12308
2025
Q1
Sell
-25,700
Closed -$92.5K 14552
2024
Q4
$92.5K Sell
25,700
-59,400
-70% -$295K ﹤0.01% 11591
2024
Q3
$485K Buy
85,100
+36,200
+74% +$218K ﹤0.01% 8324
2024
Q2
$226K Sell
48,900
-4,700
-9% -$28K ﹤0.01% 9675
2024
Q1
$438K Sell
53,600
-39,400
-42% -$305K ﹤0.01% 8675
2023
Q4
$525K Buy
93,000
+84,400
+981% +$192K ﹤0.01% 7987
2023
Q3
$16K Sell
8,600
-23,100
-73% -$70.5K ﹤0.01% 12793
2023
Q2
$87.2K Buy
31,700
+2,300
+8% +$7.39K ﹤0.01% 11135
2023
Q1
$92.3K Buy
29,400
+19,800
+206% +$117K ﹤0.01% 11378
2022
Q4
$56.6K Sell
9,600
-6,000
-38% -$49.8K ﹤0.01% 11969
2022
Q3
$137K Buy
15,600
+4,400
+39% +$45.7K ﹤0.01% 10808
2022
Q2
$84K Sell
11,200
-9,300
-45% -$81.8K ﹤0.01% 11560
2022
Q1
$497K Buy
20,500
+2,000
+11% +$48.6K ﹤0.01% 9413
2021
Q4
$596K Buy
18,500
+11,400
+161% +$451K ﹤0.01% 9238
2021
Q3
$317K Sell
7,100
-14,600
-67% -$625K ﹤0.01% 10948
2021
Q2
$821K Buy
+21,700
New +$777K ﹤0.01% 8875

Other funds holding CCCC